Piceatannol and skin

What 2 graded rows on piceatannol agree on for skin, and where they differ. Counted side by side, never averaged.

Consensus finder Rows from the Piceatannol page, reviewed Oct 21, 2026 How it decides

What the rows agree on

Each block and row is one graded row from the Piceatannol page, with its PubMed record.

Supplement

Piceatannol Choose another

2 rows · 114 people

Split. 1 row found an improvement and 1 had mixed results.

Mixed

Improved

Each block is one evidence row, sized by how many people it enrolled, with its grade inside. Outlined: mixed results.

From the rows

The best-graded row, grade D, is a randomized trial of 82 people (2026) and found an improvement.

The rows run from 32 to 82 people, published from 2018 to 2026: 2 single studies.

1 improved · 1 mixed

Grade DFacial skin hydration and wrinkles · Improved
RCT · n 82 · 2026 · Healthy Japanese women aged 30–59
10 mg/day · 8 weeks
Stratum corneum hydration rose and wrinkle grades improved vs placebo.
Row on the Piceatannol page · PubMed 42131241 (opens PubMed)
Grade DSkin moisture in women with dry skin · Mixed
RCT · n 32 · 2018 · Healthy Japanese women aged 35–54 with dry skin
5 mg piceatannol/day · 8 weeks
Moisture improved in women with the driest skin (subgroup); water loss fell non-significantly; fatigue and perspiration questionnaire scores improved.
Row on the Piceatannol page · PubMed 29491276 (opens PubMed)